Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RAwEAFJsLuzZ-2dMB67LDWGeCFsAEvposhL77ZKlWmQXY#assertion>. }
Showing items 1 to 10 of
10
with 100 items per page.
- association type Statement assertion.
- association label "unituxin dinutuximab is indicated in combination with granulocyte macrophage colony stimulating factor gm csf interleukin 2 il 2 and 13 cis retinoic acid ra for the treatment of pediatric patients with high risk neuroblastoma who achieve at least a partial response to prior first line multiagent multimodality therapy see clinical studies 14 unituxin is a gd2 binding monoclonal antibody indicated in combination with granulocyte macrophage colony stimulating factor gm csf interleukin 2 il 2 and 13 cis retinoic acid ra for the treatment of pediatric patients with high risk neuroblastoma who achieve at least a partial response to prior first line multiagent multimodality therapy 1" assertion.
- association object DOID_769 assertion.
- association predicate treats assertion.
- association subject drugbank:DB09077 assertion.
- association relation TreatmentIndication assertion.
- DOID_769 category Disease assertion.
- drugbank:DB09077 category Drug assertion.
- association provided_by NeuroDKG assertion.
- association association_type ChemicalToDiseaseOrPhenotypicFeatureAssociation assertion.